Khatri, Aparajita <br/><br/>
Cytosine deaminase-uracil phosphoribosyltransferase and interleukin (IL)-12 and IL-18: a multimodal anticancer interface marked by specific modulation in serum cytokines.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Apr 2009 
 - 2323-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-08-2039  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Combined Modality Therapy<br/>Cytokines--blood<br/>Cytosine Deaminase--genetics<br/>Flucytosine--therapeutic use<br/>Interleukin-12--genetics<br/>Interleukin-18--genetics<br/>Lung Neoplasms--secondary<br/>Lymphocytes, Tumor-Infiltrating--immunology<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Pentosyltransferases--genetics<br/>Prodrugs--therapeutic use<br/>Prostatic Neoplasms--immunology<br/>Survival Analysis<br/>Th2 Cells--immunology